Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Brem, 1995, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas, Lancet, 345, 1008, 10.1016/S0140-6736(95)90755-6
K.E. Byrd, E.L. Hamilton-Byrd, Polymeric delivery of neurotransmitters and neuromodulators, in: A.J. Domb (Ed.), Polymeric Site-Specific Pharmacotherapy, Wiley, Chichester, England, 1994, pp. 141–155.
D.P. Cain, Kindling and the amygdala, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 539–560.
Domb, 1991, Drug delivery to the brain using polymers, Crit. Rev. Ther. Drug Carrier Syst., 8, 1
A.J. Domb, Implantable biodegradable polymers for site-specific drug delivery, in: A.J. Domb (Ed.), Polymeric Site-Specific Pharmacotherapy, Wiley, Chichester, England, 1994, pp. 1–26.
Eymin, 1993, Distribution of Thyrotropin-releasing hormone binding sites: autoradiographic study in infant and adult human hippocampal formation, Brain. Res., 605, 139, 10.1016/0006-8993(93)91365-Y
Gershengorn, 1996, Molecular and cellular biology of Thyrotropin-releasing hormone receptors, Physiol. Rev., 76, 175, 10.1152/physrev.1996.76.1.175
P. Gloor, Role of the amygdala in temporal lobe epilepsy, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 505–538.
Goddard, 1969, A permanent change in brain function resulting from daily electrical stimulation, Exp. Neurol., 25, 295, 10.1016/0014-4886(69)90128-9
Gombotz, 1995, Biodegradable polymers for protein and peptide drug delivery, Bioconjugate Chem., 6, 332, 10.1021/bc00034a002
Guiloff, 1989, Use of TRH analogues in motorneuron disease, Ann. N.Y. Acad. Sci., 553, 399, 10.1111/j.1749-6632.1989.tb46662.x
Inanaga, 1989, Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy, Epilepsia, 30, 438, 10.1111/j.1528-1157.1989.tb05323.x
Knoblach, 1994, Thyrotropin-releasing hormone release is enhanced in hippocampal slices after electroconvulsive shock, J. Neurochem., 62, 119, 10.1046/j.1471-4159.1994.62010119.x
Knoblach, 1997, Increases in Thyrotropin-releasing hormone mRNA expression induced by a model of human temporal lobe epilepsy: Effect of partial and complete kindling, Neuroscience, 76, 85, 10.1016/S0306-4522(96)00361-2
Knoblach, 1997, Changes in Thyrotropin-releasing hormone levels in hippocampal subregions induced by a model of human temporal lobe epilepsy: Effect of partial and complete kindling, Neuroscience, 76, 97, 10.1016/S0306-4522(96)00362-4
Koenig, 1996, Thyrotropin-releasing hormone (TRH) attenuates glutamate-stimulated increases in calcium in primary neuronal cultures, Brain Res., 730, 143
M.J. Kubek, Thyrotropin-releasing hormone: localization of specific hypothalamic and extrahypothalamic sites of CNS modulation, in: R.C.A. Frederickson, H. Hendrie, J.N. Hingtgen, M.H. Aprison (Eds.), Neuroregulation of Autonomic, Endocrine and Immune Systems, Martinus-Nijhoff, Boston, 1986, pp. 265–301.
Kubek, 1993, Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures, Ann. Neurol., 33, 70, 10.1002/ana.410330112
Kubek, 1996, Single implantation of polymeric-TRH microdisks suppress kindled epileptogenesis in the rat, Soc. Neurosci., 22, 2109
Kubek, 1977, The identification of thyrotropin releasing hormone (TRH) in hypothalamic and extrahypothalamic loci of the human nervous system, Brain. Res., 126, 196, 10.1016/0006-8993(77)90230-X
Kubek, 1989, Role of TRH in seizure modulation, Ann. N.Y. Acad. Sci., 553, 286, 10.1111/j.1749-6632.1989.tb46650.x
Lexow, 1990, Alterations in TRH receptors in discreet regions of the hippocampus in temporal lobe epilepsy, Soc. Neurosci., 16, 447
Loscher, 1997, Animal models of intractable epilepsy, Prog. Neurobiol., 53, 239, 10.1016/S0301-0082(97)00035-X
Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6
Manaker, 1986, Autoradiographic localization of thyrotropin releasing hormone receptors in human brain, Neurology, 36, 641, 10.1212/WNL.36.5.641
Manaker, 1985, Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system, J. Neurosci., 5, 167, 10.1523/JNEUROSCI.05-01-00167.1985
J.B. Martin, S. Reichlin, G.M. Brown, Regulation of TSH secretion and its disorders, in: J.B. Martin (Ed.), Clinical Neuroendocrinology, F.A. Davis, Philadelphia, 1977, pp. 201–228.
Matsuishi, 1983, A pilot study on the anticonvulsive effects of a thyrotropin-releasing hormone analog in intractable epilepsy, Brain Dev., 5, 421, 10.1016/S0387-7604(83)80049-7
Matsumoto, 1987, Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: A comparative study with ACTH therapy, Epilepsia, 28, 49, 10.1111/j.1528-1157.1987.tb03622.x
McNamara, 1994, Cellular and molecular basis of epilepsy, J. Neurosci., 14, 3417, 10.1523/JNEUROSCI.14-06-03413.1994
J.O. McNamara, Drugs effective in the therapy of the epilepsies, in: J.G. Hardman, A. Goodman Gilman, L.E. Limbird (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, McGraw Hill, New York, 1996, pp. 461–486.
J.O. McNamara, D.W. Bonhaus, C. Shin, The kindling model of epilepsy, in: P.A. Schwartzkroin (Ed.), Epilepsy: Models, Mechanisms, and Concepts, Cambridge University Press, Cambridge, 1993, pp. 27–47.
Momiyama, 1996, Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats, Epilepsia, 37, 328, 10.1111/j.1528-1157.1996.tb00567.x
Mori, 1992, Anticonvulsant effect of DN-1417, a derivative of Thyrotropin-Releasing hormone, and liposome-entrapped DN-1417, on amygdaloid-kindled rats, Epilepsia, 33, 994, 10.1111/j.1528-1157.1992.tb01749.x
Nemeroff, 1989, Thyrotropin-releasing hormone (TRH), the thyroid axis, and affective disorder, Ann. N.Y. Acad. Sci., 553, 304, 10.1111/j.1749-6632.1989.tb46651.x
Nemeroff, 1975, Thyrotropin-releasing hormone (TRH) and its beta-alanine analogue: potentiation of the anticonvulsant potency of phenobarbital in mice, Psychopharmacology, 1, 305
Nie, 1997, TRH inhibits [K+]-stimulated glutamate release from hippocampal slices in vitro, Soc. Neurosci., 23, 2314
Ogawa, 1985, Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures, Regul. Pept., 12, 249, 10.1016/0167-0115(85)90066-7
G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, NY, 1986, pp. 1–120.
Racine, 1972, Modification of seizure activity by electrical stimulation: I. after-discharge threshold, Electroencephalogr. Clin. Neurophysiol., 32, 269, 10.1016/0013-4694(72)90176-9
R.J. Racine, G.O. Ivy, N.W. Milgram, Kindling: clinical relevance and anatomical substrate, in: T.G. Bolwig, M.R. Trimble (Eds.), The Clinical Relevance of Kindling, Wiley, New York, 1989, pp. 15–34.
Ron, 1993, Controlled release of polypeptides from polyanhydrides, Proc. Natl. Acad. Sci. USA, 90, 4176, 10.1073/pnas.90.9.4176
Rosen, 1994, Contingent tolerance to carbamazepine: alterations in TRH mRNA and TRH receptor binding in limbic structures, Brain Res., 651, 252, 10.1016/0006-8993(94)90704-8
Sakai, 1991, Effect of DN-1417 on photosensitivity and cortically kindled seizure in Senegalese Baboons, Papio papio, Epilepsia, 32, 16, 10.1111/j.1528-1157.1991.tb05604.x
Sato, 1984, Antiepileptic effects of thyrotropin-releasing hormone and its new derivative, DN-1417, examined in feline amygdaloid kindling preparation, Epilepsia, 25, 537, 10.1111/j.1528-1157.1984.tb03458.x
M. Schmutz, K. Klebs, Kindling and antiepileptic drugs, in: T.G. Bolwig, M.R. Trimble (Eds.), The Clinical Relevance of Kindling, Wiley, New York, 1989, pp. 55–68.
Sharif, 1989, Quantitative autoradiography of TRH receptors in discrete brain regions of different mammalian species, Ann. N.Y. Acad. Sci., 553, 147, 10.1111/j.1749-6632.1989.tb46638.x
Tabata, 1994, Injectable polyanhydride granules provide controlled release of water-soluble drugs with a reduced initial burst, J. Pharm. Sci., 83, 5, 10.1002/jps.2600830104
Takeuchi, 1996, Thyrotropin-releasing hormone (Protirelin): role in the treatment of epilepsy, CNS Drugs, 6, 341, 10.2165/00023210-199606050-00001
Takeuchi, 1995, Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites, Pediatr. Neurol., 12, 139, 10.1016/0887-8994(94)00149-V
Ujihara, 1991, Inhibition by thyrotropin-releasing hormone of epileptic seizures in spontaneously epileptic rats, Eur. J. Pharmacol., 196, 15, 10.1016/0014-2999(91)90403-D
Wan, 1997, Intrahippocampal injections of TRH produces anticonvulsant effects in amygdala kindled rats, Soc. Neurosci., 23, 2160
S.R.B. Weiss, M. Clark, J.B. Rosen, M.A. Smith, R.M. Post, Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms, Brain Res. Rev., 1995, pp. 305–325.